Xiangpeng Chu

410 total citations
26 papers, 191 citations indexed

About

Xiangpeng Chu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiangpeng Chu has authored 26 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Xiangpeng Chu's work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (6 papers). Xiangpeng Chu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (6 papers). Xiangpeng Chu collaborates with scholars based in China, Macao and United States. Xiangpeng Chu's co-authors include Wen‐Zhao Zhong, Yi‐Long Wu, Jia‐Tao Zhang, Xue‐Ning Yang, Peijian He, Qiang Nie, Wen‐Fang Tang, Zhen‐Bin Qiu, Rui Fu and Chao Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Advanced Science.

In The Last Decade

Xiangpeng Chu

22 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangpeng Chu China 8 105 48 45 32 30 26 191
Connor Lynch United States 5 65 0.6× 81 1.7× 44 1.0× 34 1.1× 45 1.5× 14 213
Sunil Parimi Canada 7 91 0.9× 57 1.2× 26 0.6× 44 1.4× 37 1.2× 18 142
Jarey H. Wang United States 8 40 0.4× 43 0.9× 52 1.2× 77 2.4× 25 0.8× 13 184
Jessica Burns United Kingdom 7 84 0.8× 48 1.0× 31 0.7× 23 0.7× 25 0.8× 15 158
Alina Fuerea France 8 93 0.9× 86 1.8× 37 0.8× 24 0.8× 65 2.2× 28 167
Mojca Unk Slovenia 6 117 1.1× 134 2.8× 24 0.5× 69 2.2× 23 0.8× 14 193
Arnaldo Marín Chile 5 48 0.5× 61 1.3× 52 1.2× 33 1.0× 19 0.6× 12 136
Qing Bi China 7 49 0.5× 63 1.3× 31 0.7× 34 1.1× 32 1.1× 8 148
Meng-Xia Zhang China 8 46 0.4× 68 1.4× 51 1.1× 23 0.7× 46 1.5× 8 208
J. De Langen Netherlands 7 99 0.9× 124 2.6× 28 0.6× 32 1.0× 22 0.7× 18 159

Countries citing papers authored by Xiangpeng Chu

Since Specialization
Citations

This map shows the geographic impact of Xiangpeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangpeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangpeng Chu more than expected).

Fields of papers citing papers by Xiangpeng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangpeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangpeng Chu. The network helps show where Xiangpeng Chu may publish in the future.

Co-authorship network of co-authors of Xiangpeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangpeng Chu. A scholar is included among the top collaborators of Xiangpeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangpeng Chu. Xiangpeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Lin, Yuzhong Peng, Louise Leong, et al.. (2025). CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages. Advanced Science. e11330–e11330.
2.
Li, Lei, Jingbo Zhou, Yuzhong Peng, et al.. (2025). Proteasomes suppress anticancer drug-induced cytotoxicity by inhibiting mitochondrial protein import and promoting ROS-BNIP3-mediated mitophagy. Drug Resistance Updates. 83. 101294–101294.
3.
Tang, Dongyang, Shiqi Lin, Jingbo Zhou, et al.. (2025). Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer. Cell Reports Medicine. 6(7). 102211–102211. 1 indexed citations
4.
Chen, Ping, Jingbo Zhou, Xiangpeng Chu, et al.. (2024). Establishing a cryopreserved biobank of living tumor tissues for drug sensitivity testing. Bioactive Materials. 46. 582–596. 2 indexed citations
5.
Qiu, Zhen‐Bin, Xiangpeng Chu, Yabin Hu, et al.. (2024). EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities. Annals of Surgical Oncology. 32(7). 4641–4649. 1 indexed citations
6.
Sun, Ying, Xiangpeng Chu, Xiaoyin Bai, et al.. (2024). Risk of comorbidity of autoimmune liver disease in patients with inflammatory bowel disease: A single‐center case–control study in China. Journal of Digestive Diseases. 25(9-10). 587–593.
7.
Qiu, Zhen‐Bin, Chao Zhang, Wen‐Fang Tang, et al.. (2023). Proteomic characteristics of lung adenocarcinoma tumors that are small but highly invasive. SHILAP Revista de lepidopterología. 1(4). 340–352. 5 indexed citations
8.
Chu, Xiangpeng, Shaohong Huang, Xiao Yi, et al.. (2023). A novel image deep learning–based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign. European Radiology. 34(3). 2048–2061. 9 indexed citations
9.
Zhang, Jia‐Tao, Juan Zhang, Li‐Xu Yan, et al.. (2023). Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma. iScience. 26(10). 107699–107699. 5 indexed citations
10.
Fu, Rui, Jia‐Tao Zhang, Rongrong Chen, et al.. (2022). Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk. Translational Lung Cancer Research. 11(4). 509–522. 6 indexed citations
11.
Qiu, Zhen‐Bin, Chao Zhang, Rui Fu, et al.. (2022). Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25. Thoracic Cancer. 13(22). 3174–3182. 5 indexed citations
12.
Chu, Xiangpeng, Jia‐Tao Zhang, Zhaowen Qiu, et al.. (2021). Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodules. Translational Lung Cancer Research. 10(4). 1711–1719. 8 indexed citations
13.
Chu, Xiangpeng, Jia‐Tao Zhang, Rui Fu, et al.. (2021). Precise resection of multiple pulmonary nodules using a three‐dimensional reconstruction model: A case report. Thoracic Cancer. 12(6). 970–973. 2 indexed citations
14.
Kang, Jin‐Hyoung, Peng Li, Bao Ting Zhu, et al.. (2021). Clinicopathological features and resistance mechanisms in HIP1‐ALK‐rearranged lung cancer: A multicenter study. Genes Chromosomes and Cancer. 61(4). 177–186. 6 indexed citations
15.
Qiu, Zhen‐Bin, Chao Zhang, Xiangpeng Chu, et al.. (2020). Quantifying invasiveness of clinical stage IA lung adenocarcinoma with computed tomography texture features. Journal of Thoracic and Cardiovascular Surgery. 163(3). 805–815.e3. 14 indexed citations
16.
Zhang, Jia‐Tao, Song Dong, Xiangpeng Chu, et al.. (2020). Randomized Trial of an Improved Drainage Strategy Versus Routine Chest Tube After Lung Wedge Resection. The Annals of Thoracic Surgery. 109(4). 1040–1046. 16 indexed citations
17.
Tang, Wen‐Fang, Jun‐Tao Lin, Jinghua Chen, et al.. (2020). A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 1503–1503. 3 indexed citations
18.
Chu, Xiangpeng, Jia‐Tao Zhang, Qiang Nie, et al.. (2020). Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients. Thoracic Cancer. 11(8). 2279–2290. 48 indexed citations
19.
Fu, Rui, Chao Zhang, Jia‐Tao Zhang, et al.. (2020). A three-dimensional printing navigational template combined with mixed reality technique for localizing pulmonary nodules. Interactive Cardiovascular and Thoracic Surgery. 32(4). 552–559. 8 indexed citations
20.
Zhao, Luqing, Thomas B. Bartnikas, Xiangpeng Chu, et al.. (2018). Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKCα‐dependent manner. The FASEB Journal. 33(3). 3549–3561. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connor Lynch Breakdown of academic impact, for papers by Sunil Parimi Breakdown of academic impact, for papers by Jarey H. Wang Breakdown of academic impact, for papers by Jessica Burns Breakdown of academic impact, for papers by Alina Fuerea Breakdown of academic impact, for papers by Mojca Unk Breakdown of academic impact, for papers by Arnaldo Marín Breakdown of academic impact, for papers by Qing Bi Breakdown of academic impact, for papers by Meng-Xia Zhang Breakdown of academic impact, for papers by J. De Langen
Rankless by CCL
2026